Recent Therapeutic Breakthroughs in the Treatment and Management of Pancreatic Cancer: Expert Strategies for Improved Patient Outcomes.
| Publicado en: | Journal of Managed Care Medicine Vol. 24; no. 2; pp. 10 - 14 |
|---|---|
| Autor principal: | |
| Formato: | tables/charts Journal Article |
| Publicado: |
National Association of Managed Care Physicians, Inc.
2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=151792604&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 151792604 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10941525 9084 jtl: Journal of Managed Care Medicine issn: 10941525 maglogo: N pubinfo: dt: 2021 vid: 24 iid: 2 pid: 54351 pub: National Association of Managed Care Physicians, Inc. place: Glen Allen, Virginia artinfo: ui: 151792604 151792604 151792604 151792604 ppf: 10 ppct: 4 formats: fmt: @attributes: type: P tig: atl: Recent Therapeutic Breakthroughs in the Treatment and Management of Pancreatic Cancer: Expert Strategies for Improved Patient Outcomes. aug: au: Pishvaian, Michael J. affil: Associate Professor in the Department of Oncology at Johns Hopkins University School of Medicine and Director of the Gastrointestinal, Developmental Therapeutics, and Clinical Research Programs at the NCR Kimmel Cancer Center at Sibley Memorial Hospital in Houston, TX sug: subj: Pancreatic Neoplasms Therapy Outcomes (Health Care) Chemotherapy, Cancer Tumor Markers, Biological Genetic Screening Platinum Compounds Therapeutic Use Gemcitabine Therapeutic Use Paclitaxel Therapeutic Use Irinotecan Therapeutic Use Genetic Profile Mutation Immunotherapy Immune Checkpoint Inhibitors Therapeutic Use Transferases Antagonists and Inhibitors pubtype: Academic Journal doctype: tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|